The Evidence Gap in Medication Reconciliation
Medication reconciliation is a foundational safety process: clinicians compile an accurate list of a patient’s current medications, compare it with new prescriptions and changes across care transitions, and resolve discrepancies. Done well, it reduces avoidable harm. Done poorly, it leaves patients exposed to duplications, omissions, dosing errors, and dangerous interactions. Yet reconciliation is rarely a simple list-building exercise. It demands literature checks—rapid, context-aware retrieval of evidence about drug interactions, renal and hepatic adjustments, off-label uses, deprescribing strategies, and shifting guideline recommendations. For hospitalists, family physicians, primary care teams, and pharmacists, the evidence gap is real: the information exists, but it is scattered across journals, guideline repositories, product monographs, and institutional protocols.
Traditional workflows often force clinicians to choose between speed and depth. EHR alerts can flag a potential interaction but may lack the nuanced context needed to decide whether the alert matters for a specific patient. A busy hospitalist reconciling medications at discharge may not have time to search several databases, appraise primary studies, and confirm whether a recent trial or guideline update changes the plan. A primary care pharmacist reviewing a frail older adult on twelve medications may need to check whether a new symptom is attributable to a drug interaction, a prescribing cascade, or a changing renal function. The cognitive load is substantial, and the stakes are high.
This is where AI-supported literature checks enter the conversation—not as a replacement for clinical judgment, but as a retrieval and synthesis aid. The goal is to help clinicians surface relevant evidence faster, with citations that point back to primary sources. AI can assist with the “finding” and “organizing” parts of evidence retrieval, but the “interpreting” and “deciding” parts remain firmly human. Any AI-generated answer should be treated as a starting point for verification, not a final answer. The clinician still needs to appraise the evidence, consider the patient’s unique context, and confirm that the cited source actually supports the conclusion. In reconciliation, where small details matter, that verification step is non-negotiable.
How AI Tools Support Literature Checks During Reconciliation
AI tools for clinical evidence retrieval are increasingly designed to accept natural language questions and return evidence-based responses with citations and links to source materials such as peer-reviewed journals and clinical guidelines. During medication reconciliation, a clinician might ask: “What is the latest evidence on apixaban dosing in severe renal impairment?” or “Are there recent guidelines on deprescribing benzodiazepines in older adults with falls?” A well-designed tool can help surface relevant literature, summarize key findings, and provide citation trails for deeper reading. This can be particularly useful when the evidence base is evolving, when multiple guidelines exist, or when a patient’s situation falls between the lines of standard recommendations.
One example of a clinical decision support tool for healthcare professionals is ZoeMD, which answers clinical questions typed or spoken in natural language and returns evidence-based responses with citations and links to source materials such as peer-reviewed journals and clinical guidelines. It is available on desktop, tablet, and mobile. For pharmacists and physicians who need to verify a dosing decision or check a newly published interaction, a medical AI for pharmacists can accelerate evidence retrieval without replacing the clinician’s critical appraisal. The value is not in receiving a definitive answer, but in reducing the time spent searching and orienting to the literature—so that more time can be spent on contextualizing the evidence for the patient at hand.
That said, AI-supported literature checks have limitations that clinicians must keep in mind. An AI tool may not capture every relevant study, may summarize a guideline without the full nuance of the source document, or may return citations that require careful reading to confirm applicability. Verification against cited primary sources is essential. AI can help identify a relevant trial or guideline, but the clinician must read the citation, assess the study design, consider the population and setting, and decide whether the evidence applies to the patient. In medication reconciliation, where decisions often involve trade-offs between bleeding risk, renal function, fall risk, and polypharmacy, that contextual judgment cannot be outsourced. AI supports the process; it does not replace the clinician’s reasoning.
Integrating AI-Assisted Evidence Checks into EHR-Centred Workflows
For AI-supported literature checks to be useful during medication reconciliation, they must fit into EHR-centred workflows without adding friction. Clinicians need access at the point of care—on a desktop during order entry, on a tablet during rounds, or on a mobile device during a transitions-of-care conversation. The best use cases are often brief, focused questions that arise mid-reconciliation: “Is this interaction clinically significant in a patient with CKD stage 4?” or “Has the guideline changed for diuretic dosing in heart failure?” A quick evidence retrieval step can help clinicians decide whether to adjust a dose, order a monitoring test, or seek a specialist consult. The tool should support the workflow, not become a separate destination that pulls clinicians away from the patient record.
Privacy and HIPAA considerations are part of the workflow conversation. Clinicians should avoid entering identifiable patient information into any AI tool unless institutional policy permits it and appropriate safeguards are in place. Where possible, use de-identified or hypothetical details when framing a literature question. Organizations should have clear guidance on which tools are approved for clinical use, what data can be entered, and how citations should be documented in the medical record. These are general considerations, not claims about any specific product. The key principle is that AI-assisted evidence retrieval should be governed by the same privacy and security expectations as other clinical software—and clinicians should follow their institution’s policies.
Real-world scenarios illustrate the potential. A hospitalist discharging a patient with heart failure and chronic kidney disease may be reconciling a diuretic regimen and wondering whether recent evidence supports a different dosing strategy. An AI-supported literature check can surface relevant guidelines and trials with citations, allowing the hospitalist to quickly review the evidence and document the rationale. A primary care pharmacist reviewing an older adult with polypharmacy and cognitive concerns may use an AI tool to check for recent deprescribing guidance or anticholinergic burden literature, then verify the source before making a recommendation. In each case, the AI tool accelerates the evidence retrieval step, but the clinician remains responsible for interpreting the evidence, confirming the citation, and applying it to the patient. That balance—AI as support, clinical judgment as the final authority—is what makes AI-assisted literature checks a practical addition to medication reconciliation rather than a replacement for clinical reasoning.
